Healthium Medtech, one of India’s largest homegrown medical device makers, signed a memorandum of understanding with the Andhra Pradesh Economic Development Board (APEDB) to expand its manufacturing footprint in Sri City Industrial Park. The company plans to invest Rs 150 crore in two phases to set up a second unit on five acres, adding to its existing facility that began operations in 2012.
The new plant will boost production of surgical and post-surgical devices and create 300 direct jobs by 2027, alongside 100 indirect roles in supply chain and ancillary services. The expansion comes as India’s medtech market is projected to hit $30 billion by 2030, driving demand for advanced manufacturing and skilled labor.
"This decision is driven by the rising need for resilient, high-quality manufacturing in the medtech space," said Anish Bafna, CEO and Managing Director of Healthium. "Sri City offers industrial readiness, connectivity and a skilled workforce, giving us a strong foundation to scale."
Group CFO Sudeep Dhariwal said the investment reflects Healthium's "disciplined approach to long-term capital allocation" and aims to optimize costs and improve operational efficiency. State officials hailed the move as a boost to Andhra Pradesh's ambition of building a future-ready medical device corridor.
Healthium, which supplies products used in one in five surgeries globally, operates six manufacturing facilities certified by global regulators including USFDA, CDSCO, TGA and CE under EUDMR norms. The company exports to over 90 countries and has launched more than 35 new products in the past four years.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
